Radiation Response Biomarkers for Individualised Cancer Treatments

• Muut tekijät: Badie, Christophe (Toimittaja), Rutten, Eric Andreas (Toimittaja)
• Aineistotyyppi: Elektroninen Kirjan osa
• Kieli: englanti
• Julkaistu: Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
• Aiheet: Medicine; carbon-ion radiotherapy; head-and-neck tumors; squamous cell carcinoma; radiosensitivity; relative biological effectiveness; lung cancer; radiotherapy; radiotherapy monitoring; radiation-induced lung injury; RILI; pneumonitis; radiation-induced lung fibrosis; RILF; circulating biomarkers; microRNA; micronuclei; uterine cervical cancer; cGAS; STING; abscopal effect; immunotherapy; PBMCS; micronucleus assay; biological dosimetry; human blood; genotoxicity tests; ionizing radiation; biomarkers; dicentric assay; gamma H2AX foci assay; health surveillance analyses; clonogenic assays; methods; plating; cancer; radiation; head and neck cancer; exosomes; serum; metabolomics; GC/MS; biodosimetry; chromosome aberrations; normal tissue toxicity; predictive tests; normal tissue; biomarker; protein; immune infiltrate; stroma; tumour microenvironment; proteomics; telomeres; chromosomal instability; inversions; prostate cancer; IMRT; machine learning; individual radiosensitivity; late effects; personalized medicine; liquid biopsy; circulating tumour cells; extracellular vesicles; microRNAs; immune system; inflammation; n/a
• Linkit: DOAB: download the publication; DOAB: description of the publication

Personalised medicine is the next step in healthcare, especially when applied to genetically diverse diseases such as cancers. Naturally, a host of methods need to evolve alongside this, in order to allow the practice and implementation of individual treatment regimens. One of the major tasks for th...